Additionally, we identified novel urine biomarkers IL4, MMP1, MMP2, MMP9 and N-cadherin, which are significantly elevated in IC/BPS patients compared to controls. This evidence concerns the gene CDH2 and Bartsocas-Papas syndrome 1.